OraLiva, Inc. has been awarded a prestigious Direct to Phase II SBIR grant from the National Institute of Dental and Craniofacial Research (NIDCR) at the National Institutes of Health (NIH). This funding supports the continued development of our groundbreaking AI-linked cytomics-on-a-chip platform.
CareQuest Innovation Partners Case Study: OraLiva and the Future of Oral Cancer Diagnostics
OraLiva was recently highlighted by CareQuest Innovation Partners in their SMILE Health program case study. The feature outlines how OraLiva’s AI-powered brush biopsy is addressing the challenge of late oral cancer detection by bringing lab-quality cytology into the dental chair.

